date,title,source
Oct-31-18,Scholar Rock to Present at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
Nov-09-18,Scholar Rock Demonstrates that Highly Specific TGF1 Inhibition Combined with Anti-PD1 Drives Tumor Regression and Survival Benefit in Preclinical Models of Primary Resistance to Checkpoint Blockade Therapy,GlobeNewswire
Nov-19-18,Scholar Rock Announces the Addition of Edward (Ted) Myles to Its Board of Directors,GlobeNewswire
Nov-27-18,Scholar Rock Announces Publication of Preclinical Data on the Therapeutic Benefit of Inhibiting Myostatin Activation in Models of Spinal Muscular Atrophy,GlobeNewswire
Nov-29-18,Scholar Rock to Present at the BMO 2018 Prescriptions for Success Healthcare Conference,GlobeNewswire
